New York Life Investment Management’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,841
Closed -$1.03M 823
2024
Q4
$1.03M Buy
14,841
+122
+0.8% +$11.7K 0.01% 652
2024
Q3
$2M Buy
14,719
+699
+5% +$91.9K 0.02% 578
2024
Q2
$1.89M Buy
14,020
+123
+0.9% +$18.8K 0.02% 567
2024
Q1
$2.39M Sell
13,897
-533
-4% -$81.2K 0.02% 520
2023
Q4
$2.24M Sell
14,430
-91
-0.6% -$11.9K 0.02% 522
2023
Q3
$1.82M Buy
14,521
+91
+0.6% +$11.2K 0.02% 534
2023
Q2
$1.67M Buy
14,430
+64
+0.4% +$6.94K 0.02% 548
2023
Q1
$1.56M Buy
14,366
+30
+0.2% +$3.46K 0.02% 558
2022
Q4
$1.47M Buy
14,336
+22
+0.2% +$2.18K 0.02% 568
2022
Q3
$1.29M Sell
14,314
-1,152
-7% -$127K 0.02% 581
2022
Q2
$1.82M Buy
+15,466
New +$2.22M 0.02% 533
2015
Q4
Sell
-5,454
Closed -$323K 81
2015
Q3
$323K Buy
5,454
+633
+13% +$40.2K 0.03% 154
2015
Q2
$347K Sell
4,821
-1,029
-18% -$68.5K 0.04% 139
2015
Q1
$327K Buy
5,850
+1,910
+48% +$108K 0.04% 160
2014
Q4
$236K Buy
+3,940
New +$230K 0.03% 183

Other funds holding CE

New York Life Investment Management's CE Position: Q1 2025 in Review

New York Life Investment Management sold out of Celanese (CE) in Q1 2025, closing a stake of 14,841 shares — an estimated $1.03M sold.

New York Life Investment Management first reported a position in CE in Q4 2014 and held it in 15 quarters. The position peaked at $2.39M in Q1 2024. 457 funds tracked by Wall St. Rank hold CE as of Q1 2025.

  • New York Life Investment Management reported no remaining Celanese position as of Q1 2025 after selling out during the quarter.
  • New York Life Investment Management sold 14,841 Celanese shares in Q1 2025, an estimated $1.03M.
  • New York Life Investment Management first reported a position in Celanese in Q4 2014 and held it in 15 quarters.
  • New York Life Investment Management's Celanese position peaked at $2.39M in Q1 2024.
  • 457 funds tracked by Wall St. Rank held Celanese as of Q1 2025.

Based on New York Life Investment Management's 13F filing for Q1 2025, filed 8 May 2025.